**** SECTION 2 - COMPOSITION, INFORMATION ON INGREDIENTS ****
+----------------+--------------------------------------+----------+-----------+
| CAS# | Chemical Name | % | EINECS# |
|----------------|--------------------------------------|----------|-----------|
|----------------|--------------------------------------|----------|-----------|
| 7439-97-6 |Mercury | 0.1 | 231-106-7 |
|----------------|--------------------------------------|----------|-----------|
| 7697-37-2 |Nitric acid | 10.0 | 231-714-2 |
|----------------|--------------------------------------|----------|-----------|
| 7732-18-5 |Water | 89.9 | 231-791-2 |
+----------------+--------------------------------------+----------+-----------+
Text for R-phrases: see Section 16
Hazard Symbols: XN C
Risk Phrases: 20/21/22 33 34
**** SECTION 3 - HAZARDS IDENTIFICATION ****
EMERGENCY OVERVIEW
Harmful by inhalation, in contact with skin and if swallowed. Danger
of cumulative effects. Causes burns.
Potential Health Effects
Eye:
Causes eye burns. May cause chemical conjunctivitis and corneal
damage.
Skin:
Causes skin burns. May cause skin rash (in milder cases), and cold
and clammy skin with cyanosis or pale color.
Ingestion:
May cause severe and permanent damage to the digestive tract. Causes
gastrointestinal tract burns. May cause perforation of the digestive
tract. Inorganic mercury compounds may cause central and peripheral
nervous system effects. May cause systemic effects.
Inhalation:
May cause severe irritation of the respiratory tract with sore
throat, coughing, shortness of breath and delayed lung edema. Causes
chemical burns to the respiratory tract. Aspiration may lead to
pulmonary edema. May cause systemic effects. Acute exposure to high
concentrations of mercury vapors may cause severe respiratory tract
irritation.
Chronic:
Effects may be delayed. Chronic exposure to mercury may cause
permanent central nervous system damage, fatigue, weight loss,
tremors, personality changes. Chronic ingestion may cause
accumulation of mercury in body tissues. Chronic exposure to mercury
vapors may produce weakness, fatigue, anorexia, loss of weight and
gastrointestinal disturbances which is collectively referred to as
asthenic-vegetative syndrome or micromercurialism. Chronic exposure
to mercury compounds may produce immunologic glomerular disease.
**** SECTION 4 - FIRST AID MEASURES ****
Eyes:
Get medical aid immediately. Do NOT allow victim to rub eyes or keep
eyes closed. Extensive irrigation with water is required (at least 30
minutes).
Skin:
Get medical aid immediately. Immediately flush skin with plenty of
water for at least 15 minutes while removing contaminated clothing
and shoes. Wash clothing before reuse. Destroy contaminated shoes.
Ingestion:
Do not induce vomiting. If victim is conscious and alert, give 2-4
cupfuls of milk or water. Never give anything by mouth to an
unconscious person. Get medical aid immediately.
Inhalation:
Get medical aid immediately. Remove from exposure and move to fresh
air immediately. If breathing is difficult, give oxygen. Do NOT use
mouth-to-mouth resuscitation. If breathing has ceased apply
artificial respiration using oxygen and a suitable mechanical device
such as a bag and a mask.
Notes to Physician:
**** SECTION 5 - FIRE FIGHTING MEASURES ****
General Information:
As in any fire, wear a self-contained breathing apparatus in
pressure-demand, MSHA/NIOSH (approved or equivalent), and full
protective gear. During a fire, irritating and highly toxic gases
may be generated by thermal decomposition or combustion. Use
extinguishing media appropriate to the surrounding fire. Substance is
noncombustible. Vapors may be heavier than air. They can spread
along the ground and collect in low or confined areas.
Extinguishing Media:
Substance is noncombustible; use agent most appropriate to
extinguish surrounding fire.
**** SECTION 6 - ACCIDENTAL RELEASE MEASURES ****
General Information: Use proper personal protective equipment as indicated
in Section 8.
Spills/Leaks:
Absorb spill with inert material (e.g. vermiculite, sand or earth),
then place in suitable container. Avoid runoff into storm sewers and
ditches which lead to waterways. Clean up spills immediately,
observing precautions in the Protective Equipment section. Provide
ventilation.
**** SECTION 7 - HANDLING and STORAGE ****
Handling:
Use only in a well-ventilated area. Do not breathe dust, vapor,
mist, or gas. Do not get in eyes, on skin, or on clothing. Keep
container tightly closed. Do not ingest or inhale. Discard
contaminated shoes.
Storage:
Keep container closed when not in use. Corrosives area. Poison room
locked. Store in a cool, dry area away from incompatible substances.
**** SECTION 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION ****
Engineering Controls:
Facilities storing or utilizing this material should be equipped
with an eyewash facility and a safety shower. Use adequate
ventilation to keep airborne concentrations low.
Exposure Limits
CAS# 7439-97-6:
United States OSHA: ; 0.1 mg/m3 Ceiling (vapor)
Belgium - TWA: (listed as mercury, aryl and inorganic compounds):
mg/m3 VLE (as Hg)
France - VME: 0.05 mg/m3 VME (vapor)
Germany: 0.1 mg/m3 TWA
Japan: 0.025 mg/m3 OEL (vapor)
Malaysia: (listed as mercury, aryl and inorganic compounds): 0.1
mg/m3 TWA (as Hg)
Netherlands: 0.5 mg/m3 STEL
Netherlands: 0.05 mg/m3 MAC
Russia: 0.01 mg/m3 TWA
Russia: 0.005 mg/m3 STEL
Spain: 0.025 mg/m3 VLA-ED
CAS# 7697-37-2:
United Kingdom, WEL - TWA: 2 ppm TWA; 5.2 mg/m3 TWA
United Kingdom, WEL - STEL: 4 ppm STEL; 10 mg/m3 STEL
United States OSHA: 2 ppm TWA; 5 mg/m3 TWA
Belgium - TWA: 2 ppm VLE; 5.3 mg/m3 VLE
Belgium - STEL: 4 ppm VLE; 10 mg/m3 VLE
France - VME: 2 ppm VME; 5 mg/m3 VME
France - VLE: 4 ppm VLE; 10 mg/m3 VLE
Germany: 2 ppm TWA; 5.2 mg/m3 TWA
Japan: 2 ppm OEL; 5.2 mg/m3 OEL
Malaysia: 2 ppm TWA; 5.2 mg/m3 TWA
Netherlands: 0.5 ppm STEL; 1.3 mg/m3 STEL
Russia: 2 mg/m3 TWA
Spain: 2 ppm VLA-ED; 5.2 mg/m3 VLA-ED
Spain: 4 ppm VLA-EC; 10 mg/m3 VLA-EC
CAS# 7732-18-5:
Personal Protective Equipment
Eyes:
Wear chemical splash goggles.
Skin:
Wear appropriate protective gloves to prevent skin
exposure.
Clothing:
Wear appropriate protective clothing to prevent skin
exposure.
Respirators:
A respiratory protection program that meets OSHA's 29
CFR 1910.134 and ANSI Z88.2 requirements or European
Standard EN 149 must be followed whenever workplace
conditions warrant respirator use.
**** SECTION 9 - PHYSICAL AND CHEMICAL PROPERTIES ****
Physical State: Liquid
Color: Clear
Odor: None reported.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: Not available.
Autoignition Temperature: Not applicable.
Flash Point: Not applicable.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water: miscible
Specific Gravity/Density:
Molecular Formula: Solution
Molecular Weight: 0
**** SECTION 10 - STABILITY AND REACTIVITY ****
Chemical Stability:
Stable under normal temperatures and pressures.
Conditions to Avoid:
Incompatible materials, excess heat.
Incompatibilities with Other Materials:
Strong acids, strong bases, strong oxidizing agents.
Hazardous Decomposition Products:
Nitrogen oxides, nitrogen.
Hazardous Polymerization: Has not been reported.
**** SECTION 11 - TOXICOLOGICAL INFORMATION ****
RTECS#:
CAS# 7439-97-6: OV4550000
CAS# 7697-37-2: QU5775000 QU5900000
CAS# 7732-18-5: ZC0110000
LD50/LC50:
Not available.
CAS# 7697-37-2: Inhalation, rat: LC50 = 260 mg/m3/30M; Inhalation,
rat: LC50 = 130 mg/m3/4H; Inhalation, rat: LC50 = 67 ppm(NO2)/4H.
CAS# 7732-18-5: Oral, rat: LD50 = >90 mL/kg.
Carcinogenicity:
Mercury -
Not listed by ACGIH, IARC, or NTP.
Nitric acid -
Not listed by ACGIH, IARC, or NTP.
Water -
Not listed by ACGIH, IARC, or NTP.
Other:
See actual entry in RTECS for complete information.
**** SECTION 12 - ECOLOGICAL INFORMATION ****
**** SECTION 13 - DISPOSAL CONSIDERATIONS ****
Dispose of in a manner consistent with federal, state, and local regulations.
**** SECTION 14 - TRANSPORT INFORMATION ****
IATA
Shipping Name: NITRIC ACID
Hazard Class: 8
UN Number: 2031
Packing Group: II
IMO
Shipping Name: NITRIC ACID
Hazard Class: 8
UN Number: 2031
Packing Group: II
RID/ADR
Shipping Name: NITRIC ACID
Hazard Class: 8
UN Number: 2031
Packing group: II
USA RQ: CAS# 7439-97-6: 1 lb final RQ; 0.454 kg final RQ
USA RQ: CAS# 7697-37-2: 1000 lb final RQ; 454 kg final RQ
**** SECTION 15 - REGULATORY INFORMATION ****
European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: XN C
Risk Phrases:
R 20/21/22 Harmful by inhalation, in contact with
skin and if swallowed.
R 33 Danger of cumulative effects.
R 34 Causes burns.
Safety Phrases:
S 23 Do not inhale gas/fumes/vapour/spray.
S 26 In case of contact with eyes, rinse immediately
with plenty of water and seek medical advice.
S 36 Wear suitable protective clothing.
S 45 In case of accident or if you feel unwell, seek
medical advice immediately (show the label where
possible).
WGK (Water Danger/Protection)
CAS# 7439-97-6: 3
CAS# 7697-37-2: 1
CAS# 7732-18-5: No information available.
Canada
CAS# 7439-97-6 is listed on Canada's DSL List.
CAS# 7697-37-2 is listed on Canada's DSL List.
CAS# 7732-18-5 is listed on Canada's DSL List.
CAS# 7439-97-6 is listed on Canada's Ingredient Disclosure List.
CAS# 7697-37-2 is listed on Canada's Ingredient Disclosure List.
CAS# 7732-18-5 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 7439-97-6 is listed on the TSCA inventory.
CAS# 7697-37-2 is listed on the TSCA inventory.
CAS# 7732-18-5 is listed on the TSCA inventory.
**** SECTION 16 - ADDITIONAL INFORMATION ****
Text for R-phrases from Section 2
MSDS Creation Date: 7/15/1998 Revision #6 Date: 9/19/2003
The information above is believed to be accurate and represents the best
information currently available to us. However, we make no warranty of
merchantability or any other warranty, express or implied, with respect to
such information, and we assume no liability resulting from its use. Users
should make their own investigations to determine the suitability of the
information for their particular purposes. In no way shall the company be
liable for any claims, losses, or damages of any third party or for lost
profits or any special, indirect, incidental, consequential or exemplary
damages, howsoever arising, even if the company has been advised of
the possibility of such damages.
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
|
|
|
| ALL MSDS PAGES IN THIS GROUP
| | NAME | CAS |
|
Alpha, Alpha, Alpha-Trifluoro-P-Tolunitrile, 99%
| 455-18-5 |
|
Ethyl 4-methoxybenzoate, 98%
| 94-30-4 |
|
Ethanesulfonic Acid, 95% (Titr.)
| 594-45-6 |
|
3,6-Dihydroxybenzonorbornane, 96% (uv-vis)
| 15155-91-5 |
|
Ethyl 3-Aminobenzoate, 99+%
| 582-33-2 |
|
Chromium(III)acetylacetonate, 97%
| 21679-31-2 |
|
2-(2-(Methylamino)ethyl)pyridine dihydrochloride
| 5579-84-0 |
|
2-Amino-4-chlorobenzoic acid, 98%
| 89-77-0 |
|
N-(2-Hydroxyethyl)Pyrrolidine, 95%
| 2955-88-6 |
|
2,2,2-Trifluoroethyl P-Toluenesulfonate 98%
| 433-06-7 |
|
3,4-Diethoxybenzoic Acid, 99%
| 5409-31-4 |
|
1-Octadecanol 95%
| 112-92-5 |
|
DL-2,3-Diaminopropionic Acid Monohydrochloride, 99%
| 54897-59-5 |
|
5-Methyl-3-heptanone, 96% (gc)
| 541-85-5 |
|
1-Bromo-2,2-dimethoxypropane, 97%
| 126-38-5 |
|
Phenyl 4-Aminosalicylate, 99%
| 133-11-9 |
|
Tetraethyltin, 97%
| 597-64-8 |
|
1-Piperazinepropanol, 98%
| 5317-32-8 |
|
Diethyl Methylmalonate, 99%
| 609-08-5 |
|
2,2,6,6-Tetramethylcyclohexanone, 98%
| 1195-93-3 |
|
2-Nitroresorcinol
| 601-89-8 |
|
o-Methoxycinnamic acid, predominantly trans
| 6099-03-2 |
|
4-Aminobenzyl cyanide, 99%
| 3544-25-0 |
|
2,3-Dichloropyridine, 99%
| 2402-77-9 |
|
2-Amino-1-Phenylethanol, 98%
| 7568-93-6 |
|
Dipropylene Glycol, Tech., 99% (GC) Mixture of Isomeric Propylene
| 25265-71-8 |
|
Dibenzylamine, 98%
| 103-49-1 |
|
6-Chloro-2-picoline, 98%
| 18368-63-3 |
|
Diethyl Oxalacetate Sodium Salt (PRACT)
| 40876-98-0 |
|
Cyclobutanecarboxylic Acid, 98%
| 3721-95-7 |
|
2-(2-Ethoxyethoxy)ethyl Acetate, 99%
| 112-15-2 |
|
2-Mercapto-6-Nitrobenzothiazole, 96% (Titr.)
| 4845-58-3 |
|
Dihydrocytochalasin B
| 39156-67-7 |
|
3-Chloropropylamine Hydrochloride, 98%
| 6276-54-6 |
|
2-Amino-3-Methylbenzoic Acid, 98%
| 4389-45-1 |
|
m-Phenetidine, 96% (gc)
| 621-33-0 |
|
4,4-Diphenylsemicarbazide, 98%
| 603-51-0 |
|
3-Methyl-1-pentyn-3-ol, 99+%
| 77-75-8 |
|
(R)-(+)-N-Benzyl-alpha-methylbenzylamine, 98%
| 38235-77-7 |
|
1,7-Diaza-15-Crown-5, 99%
| 31249-95-3 |
|
l-(-)-Xylose, p.a.
| 609-06-3 |
|
4-Hydroxybenzylidenemalonodinitrile, 99%
| 3785-90-8 |
|
2,2'-Dithiodipyridine, 98%
| 2127-03-9 |
|
Mercury atomic absorption standard solution, 1 mg/ml Hg in 10% HNO3
| 7439-97-6 |
|
Lissamine Rhodamine B Sulfonyl Chloride, 99+% (UV-VIS)
| 62796-29-6 |
|
2,4-Diethyl-2,6-heptadienal, 97% Mixture of Isomers
| 85136-07-8 |
|
Dimethyldiselenide, 99+%
| 7101-31-7 |
|
2-Amino-4-Hydroxy-1H-Pteridine
| 2236-60-4 |
|
Alpha-Bromo-O-Tolunitrile, 98%
| 22115-41-9 |
|
(2-Chloroethyl)trimethylammonium chloride, 98%
| 999-81-5 |
|
|